Qasim Al-Orjani earned his Doctor of Pharmacy (PharmD) degree from Jordan University of Science and Technology in 2017. He completed his pharmacy residency at the Jordanian Royal Medical Services (JRMS) in 2024, where he gained extensive clinical experience across multiple hospital settings. Currently, he is pursuing a Master of Science in Pharmacology and Toxicology at the University of Toledo. His area of research is Kidney pharmacology with a focus on the role of primary cilia in hypertension and Polycystic Kidney Disease (PKD) to develop strategies for disease therapeutics.
Qasim Al-Orjani earned his Doctor of Pharmacy (PharmD) degree from Jordan University of Science and Technology in 2017. He completed his pharmacy residency at the Jordanian Royal Medical Services (JRMS) in 2024, where he gained extensive clinical experience across multiple hospital settings. Currently, he is pursuing a Master of Science in Pharmacology and Toxicology at the University of Toledo. His area of research is Kidney pharmacology with a focus on the role of primary cilia in hypertension and Polycystic Kidney Disease (PKD) to develop strategies for disease therapeutics.